XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 808 $ 2,232
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Interest credited to policyholders’ account balances 1,879 1,520
Policy charges and fee income (1,857) (1,781)
Net derivative (gains) losses 2,298 1,143
Credit and intent to sell losses on available for sale debt securities and loans 63 145
Investment (gains) losses, net 38 409
(Gains) losses on businesses held-for-sale (135) 3
Realized and unrealized (gains) losses on trading securities (114) (17)
Non-cash long term incentive compensation expense 78 59
Amortization and depreciation 640 576
Remeasurement of liability for future policy benefits 9 46
Change in market risk benefits (1,154) (1,772)
Equity (income) loss from limited partnerships (94) (81)
Changes in:    
Net broker-dealer and customer related receivables/payables (505) (996)
Reinsurance recoverable (612) (1,106)
Segregated cash and securities, net 321 595
Capitalization of deferred policy acquisition costs (852) (702)
Future policy benefits 359 196
Current and deferred income taxes 181 (868)
Other, net 255 584
Net cash provided by (used in) operating activities 1,606 184
Proceeds from the sale/maturity/pre-payment of:    
Fixed maturities, available-for-sale 7,668 7,978
Fixed maturities, at fair value using the fair value option 630 323
Mortgage loans on real estate 1,010 353
Trading account securities 998 665
Short term investments 757 2,704
Other 488 631
Payment for the purchase/origination of:    
Fixed maturities, available-for-sale (14,781) (9,753)
Fixed maturities, at fair value using the fair value option (663) (417)
Mortgage loans on real estate (2,124) (1,567)
Trading account securities (2,074) (994)
Short term investments (389) (2,410)
Other (66) (816)
Cash settlements related to derivative instruments, net (1,974) (1,702)
Investment in capitalized software, leasehold improvements and EDP equipment (127) (82)
Other, net 328 121
Net cash provided by (used in) investing activities (10,319) (4,966)
Policyholders’ account balances:    
Deposits 13,856 12,690
Withdrawals (7,700) (6,729)
Transfers (to) from Separate Accounts 1,280 974
Payments of market risk benefits (545) (559)
Repayment of short-term financings (254) (759)
Change in collateralized pledged assets (61) (127)
Change in collateralized pledged liabilities 4,703 1,232
(Decrease) increase in overdrafts payable 0 3
Issuance of long-term debt 0 497
Repayment of long term debt (565) 0
Proceeds from collateralized loan obligations 0 40
Proceeds from notes issued by consolidated VIEs 169 362
Dividends paid on common stock (227) (227)
Dividends paid on preferred stock (54) (54)
Issuance of preferred stock 0 0
Purchase of AllianceBernstein Units (12) 0
Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net (78) (71)
Purchase of treasury shares (754) (678)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 399 161
Distribution to noncontrolling interest of consolidated subsidiaries (278) (252)
Change in securities lending 11 113
Other, net 2 (3)
Net cash provided by (used in) financing activities 9,892 6,613
Effect of exchange rate changes on cash and cash equivalents 8 (2)
Change in cash and cash equivalents 1,187 1,829
Cash and cash equivalents, beginning of period 8,239 4,281
Change in cash of businesses held-for-sale 153 (14)
Cash and cash equivalents, end of period 9,579 6,096
Non-cash transactions from investing and financing activities:    
Securities received in exchange for the 2029 Notes [1] 547 0
Right-of-use assets obtained in exchange for lease obligations $ 231 $ 48
[1] See Note 16 of the Notes to these Consolidated Financial Statements for details of the 2029 Trust Eligible Assets received in exchange for the 2029 Notes.